Joo-young Byun
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Long-term comparative effectiveness of tepotinib versus standard of care for MET exon 14 skipping-mutated non-small cell lung cancer.
Journal: Therapeutic advances in medical oncology
Published: March 26, 2026
A comparative review of economic evaluations for immune checkpoint inhibitors in early stage and advanced stage cancer: focusing on pembrolizumab.
Journal: Frontiers in pharmacology
Published: October 02, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 02, 2025
Lifetime economic burden of hemophilia using a nationwide real-world healthcare data.
Journal: PloS one
Published: February 27, 2025
Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer.
Journal: Expert opinion on drug safety
Published: December 13, 2023
Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea.
Journal: Advances in therapy
Published: September 02, 2022
A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC).
Journal: Expert opinion on pharmacotherapy
Published: June 27, 2022
Economic burden of brain metastases in non-small cell lung cancer patients in South Korea: A retrospective cohort study using nationwide claims data.
Journal: PloS one
Published: September 17, 2021
A Systematic Review of Economic Evaluations of Active Tuberculosis Treatments.
Journal: Frontiers in pharmacology
Published: July 06, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026